Federal Government Seizes Dozens of Misbranded Drug Products
Tuesday, 06 April 2010
At the request of the U.S. Food and Drug Administration, U.S. Marshals on March 31 seized a range of consumer products, including creams, capsules, tablets, gum, throat spray, and shampoos from a Haywood, Wis., manufacturer.
FDA Approves First Biodegradable Sealant Patch for Cardiovascular Surgery
Tuesday, 06 April 2010
The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.
FDA Approves New Formulation for OxyContin
Tuesday, 06 April 2010
The U.S. Food and Drug Administration today approved a new formulation of the controlled-release drug OxyContin that has been designed to help discourage misuse and abuse of the medication.
Federal Government Seeks Permanent Injunction Against Texas Egg Roll Manufacturer
Friday, 02 April 2010
The U. S. Department of Justice, in an action initiated by the U.S. Food and Drug Administration, is seeking a permanent injunction against Chung’s Products LP (“Chung’s”), an egg roll manufacturer in Houston, Charlie A. Kujawa, the company's president, and Gregory S. Birdsell, the firm's director of quality assurance.
Haitians delivering healthcare to Haitians
Friday, 02 April 2010
1 April 2010 -- In the aftermath of the earthquake in Haiti, much of the initial lifesaving care came from health workers living in the affected communities. This photo essay highlights the crucial role of Haitians in re-establishing health services in their country.
FDA Approves Asclera to Treat Small Varicose Veins
Wednesday, 31 March 2010
The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.
FDA Requires Device Manufacturers to Include Information on Pediatric Populations
Wednesday, 31 March 2010
The U.S. Food and Drug Administration announced today that will begin implementing a requirement that device manufacturers provide readily available information in certain premarket applications on pediatric patients who suffer from the disease or condition that the device is intended to treat, diagnose, or cure, even if the device is intended for adult use.
Public Health Agencies Collaborate to Prevent Further Illnesses from Norovirus Outbreak Associated with Oysters Recently Harvested from Area Near Port Sulphur, La.
Monday, 29 March 2010
The U.S. Food and Drug Administration is working with state health officials from Mississippi and Louisiana to notify consumers, food service operators and retailers nationwide about an outbreak of norovirus associated with oysters recently harvested from an area near Port Sulphur, La. known as Area 7. The oysters were sold or distributed nationwide.
FDA Takes Action Against New York Dairy Farmer
Saturday, 27 March 2010
A New York State dairy farmer cited by the U.S. Food and Drug Administration for selling cows that had illegal residues of antibiotics was ordered by the U.S. District Court for the Western District of New York this week to stop offering the animals for slaughter until he complies with federal law.
Two Arrested for Illegally Trafficking Counterfeit Weight Loss Medication
Saturday, 27 March 2010
JOINT INTERNATIONAL UNDERCOVER INVESTIGATION BY FOOD AND DRUG ADMINISTRATION OFFICE OF CRIMINAL INVESTIGATIONS, U.S. IMMIGRATION AND CUSTOMS ENFORCEMENT, AND U.S. POSTAL INSPECTION SERVICE DISRUPTS COUNTERFEIT DRUG MANUFACTURING
© Copyright 2001-2022 eDoctorOnline.com
